Speech-Language Pathologists in Bellevue, NE Accepting Medicare
69 Speech-Language Pathologists found. Showing 61 - 69
 Nancy Kirk Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7800 S 25th St, Bellevue, NE 68147 Phone: 402-734-5705 |
Mrs. Brenda Kay Cogswell, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1702 Hillcrest Dr, Bellevue, NE 68005 Phone: 402-682-4294 |
Elizabeth Humlicek Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 Lincoln Rd, Bellevue, NE 68005 Phone: 402-293-4970 |
Kayla Wies Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2202 Washington St, Bellevue, NE 68005 Phone: 402-293-4000 |
Jamie Kathleen Eberhardt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2107 Avery Rd E, Bellevue, NE 68005 Phone: 402-293-4460 |
Mrs. Kelli Kathleen Krause, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5606 S 147th St, Bellevue, NE 68137 Phone: 402-201-4635 |
Caitlin Mcdevitt Seguin, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 605 W 27th Ave, Bellevue, NE 68005 Phone: 402-293-4585 |
Corianne Marie Himes Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3001 Spring Blvd, Bellevue, NE 68123 Phone: 402-293-5070 |
 Mission Middle School Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2201 Washington St, Bellevue, NE 68005 Phone: 402-293-4260 |
News Archive
New review highlights challenges of studying resistance to antiangiogenic treatment in preclinical models
New blood vessel growth, or angiogenesis, is critical for cancer to grow and spread throughout the body.
EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.
Inadequate funding for research, prevention will not help eradicate HIV in Quebec
On the XVIII International AIDS Conference's Eve (Vienna, Austria, July 18th to 23rd 2010), Mark Wainberg, PhD, co-director at Réseau Sida/Maladies infectieuses (FRSQ) and Dr. Réjean Thomas, president of clinique médicale l'Actuel denounce chronic underfunding in research and prevention related to HIV in Quebec and it's dramatic impact on the HIV epidemic and STI's. Researchers insist that the government double the amounts dedicated to these sectors.
ISB, GIND collaborate on whole-genome sequencing to identify drug targets for Huntington's Disease
The Institute for Systems Biology (ISB) of Seattle, WA, is collaborating with the Gladstone Institute of Neurological Disease (GIND) and its Taube-Koret Center for Huntington's Disease Research to use whole-genome sequencing to identify genes and novel drug targets related to the onset and progression of Huntington's disease (HD). The research team, led by GIND associate director and senior investigator Steven Finkbeiner, MD, PhD, will also use induced pluripotent stem (iPS) cells from patients with HD to screen for drugs that might delay, prevent, or even reverse this devastating condition.
FDA approves generic Topamax tablets (topiramate)
The U.S. Food and Drug Administration has approved the first generic versions of Topamax tablets (topiramate) to prevent seizures.
› Verified 6 days ago
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Chiropractors
Optometrists
Podiatrists